1Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality,and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world [J]. Clin Oncol, 2006, 24 (14):2137-2150.
4Clemons M, Goss P. Estrogen and the risk of breast cancer[J]. N Engl J Med, 2001, 344(4):276-285.
5Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro[J]. Nutr Cancer, 1997, 27(1):31-40.
7Yang X, Yang S, McKimmey C, et al. Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/ kipl downregulation[J]. Carcinogenesis, 2010, 31(4):695- 702.
8Murata M, Midorikawa K, Koh M, et al. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs[J]. Biochemistry, 2004, 43(9):2569-2577.
9Sakamoto T, Horiguchi H, Oguma E, et al. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells [J]. Nutr Biocbem, 2010, 21(9):856-864.
10Peng JH, Zhu JD, Mi MT, et al. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis[J]. Eur J Cancer Prey, 2010, 19(2):110-119.
10Chrzan B G, Bradford P G. Phytoestrogen activate estrogen receptor betal and estrogenic responses in human breast and bone cancer cell lines[J]. Mol Nutr Food Res, 2007, 51(2): 171-177.
